Research Insight
Research Insight
Northwell Health Partners with Indivumed to Create a Cancer Research Biobank
Northwell Health announced a collaboration with Indivumed to speed the advance of precision cancer research.As New York State’s largest health care provider, Northwell Health diagnoses and treats 19,000 new cancer patients each year.
Indivumed GmbH is a Germany-based oncology research...
Research Insight
DMC cardiologist pioneers system to treat pulmonary embolisms
Thousands of people have died over the years from what originally was believed to be a heart attack when the actual cause was a massive pulmonary embolism, said Mahir Elder, M.D., a top interventional cardiologist at Detroit Medical Center's...
Research Insight
AbbVie and Johns Hopkins to Collaborate on Cancer Research
AbbVie, a global biopharmaceutical company, and the Johns Hopkins University School of Medicine today announced that they signed a five-year collaboration agreement with the goal of advancing medical oncology research and discovery at both organizations.Designed to build strong collaboration...
Research Insight
Blueprint Medicines Announces Proof-of-Concept Data from Global Phase 1 Clinical Trial of BLU-554
Blueprint Medicines Corporation , a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases announced data from its ongoing Phase 1 trial evaluating BLU-554, an investigational medicine for the treatment of advanced hepatocellular carcinoma...
Research Insight
Novartis BAF312 reduces the risk of disability progression in phase III study in secondary patients
EXPAND study data presented at ECTRIMS show that treatment with BAF312 (siponimod) reduced the risk of three-month confirmed disability progression by 21% vs placebo in people with secondary progressive multiple sclerosis (SPMS)SPMS is a progressive and highly disabling form...
Research Insight
Merck to Develop Next-Generation Purification Processes with International Vaccine Institute
Merck, a leading science and technology company, has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes. Merck will provide funding and expertise in the...
Research Insight
Johnson & Johnson Pharmaceutica NV Idylla Ebola Virus Triage Test Granted Emergency Use Authorizatio
Johnson & Johnson’s commitment to combat Ebola, Janssen Pharmaceutica NV announced that the Idylla™ Ebola Virus Triage Test (Idylla™ EBOV Test) was granted Emergency Use Authorization (EUA) by the U.S. FDA 1. The Idylla™ Ebola Virus Triage Test is a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read